Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Quantum Biopharma (QNTM) Equity Average (2024 - 2025)

Quantum Biopharma's Equity Average history spans 2 years, with the latest figure at $7.8 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 43.91% to $7.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.8 million, a 43.91% decrease, with the full-year FY2025 number at $9.2 million, changed N/A from a year prior.
  • Equity Average hit $7.8 million in Q4 2025 for Quantum Biopharma, up from $6.2 million in the prior quarter.
  • Over the last five years, Equity Average for QNTM hit a ceiling of $13.9 million in Q4 2024 and a floor of $4.7 million in Q2 2025.